在疹中通过TLR2/JAK2/STAT3轴LL37驱动的杆细胞降粒和炎症
Huiping Fan1, Rui Sun1, Qingsong Ma1
1Department of Dermatology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.
Frontiers in immunology
|December 12, 2025
概括
凯瑟利西丁LL-37通过TLR2/JAK2/STAT3通路触发粉红病中杆细胞脱粒化. 鲁克索利提尼布治疗有效地抑制了这种途径,为粉红提供了一种新的治疗策略.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 红是一种慢性炎症性皮肤疾病,原因不明.
- LL37和巨细胞与粉红病的发展有关,但确切的机制尚不清楚.
研究的目的:
- 为了阐明LL37诱导的粉红病中杆细胞脱粒化的机制.
- 为了研究ruxolitinib在粉红病小鼠模型和患者中的治疗潜力.
主要方法:
- 建立了一个与ruxolitinib.litinib治疗的罗莎性皮肤炎小鼠模型.
- 使用了组织学染色,转录组测序,西斑和免疫光.
- 进行了体外研究,包括共免疫沉和lentivirus介导的基因操纵.
- 在使用VISIA皮肤分析的粉红患者中评估鲁克索利提尼布的疗效.
主要成果:
- 在巨细胞中,LL37激活了TLR2/JAK2/STAT3通路,导致脱粒化.
- 在小鼠中,ruxolitinib治疗减少了皮肤炎症,巨细胞透和脱粒.
- LL37直接与TLR2结合,从而启动TLR2/MyD88/JAK2/STAT3信号级联.
- 局部使用的鲁克索利提尼布在粉红患者中显示出临床有效性.
结论:
- LL37通过通过TLR2/JAK2/STAT3通路激活巨细胞来驱动粉红疹病原体.
- 鲁克索利提尼布有效地抑制了这种途径,为粉红提供了有前途的治疗方法.
- 这项研究为粉红病机制和治疗策略提供了新的见解.
相关概念视频
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Inflammation
61.4K
Overview
61.4K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
Inflammatory Response
15.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.8K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
7.3K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.3K


